216 related articles for article (PubMed ID: 20394808)
1. Opioid receptor internalization contributes to dermorphin-mediated antinociception.
Macey TA; Ingram SL; Bobeck EN; Hegarty DM; Aicher SA; Arttamangkul S; Morgan MM
Neuroscience; 2010 Jun; 168(2):543-50. PubMed ID: 20394808
[TBL] [Abstract][Full Text] [Related]
2. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
[TBL] [Abstract][Full Text] [Related]
3. Drug dependent sex-differences in periaqueducatal gray mediated antinociception in the rat.
Bobeck EN; McNeal AL; Morgan MM
Pain; 2009 Dec; 147(1-3):210-6. PubMed ID: 19796879
[TBL] [Abstract][Full Text] [Related]
4. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
[TBL] [Abstract][Full Text] [Related]
5. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray.
Roychowdhury SM; Fields HL
Neuroscience; 1996 Oct; 74(3):863-72. PubMed ID: 8884782
[TBL] [Abstract][Full Text] [Related]
6. Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance.
Bobeck EN; Ingram SL; Hermes SM; Aicher SA; Morgan MM
Behav Brain Res; 2016 Feb; 298(Pt B):17-24. PubMed ID: 26497105
[TBL] [Abstract][Full Text] [Related]
7. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL
J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455
[TBL] [Abstract][Full Text] [Related]
9. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat.
Morgan MM; Bobeck EN; Ingram SL
Brain Res; 2009 Oct; 1295():59-66. PubMed ID: 19664608
[TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.
Mehalick ML; Ingram SL; Aicher SA; Morgan MM
J Pain; 2013 Dec; 14(12):1601-10. PubMed ID: 24161274
[TBL] [Abstract][Full Text] [Related]
11. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
[TBL] [Abstract][Full Text] [Related]
12. Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.
Tamaddonfard E; Erfanparast A; Salighedar R; Tamaddonfard S
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):371-379. PubMed ID: 31641818
[TBL] [Abstract][Full Text] [Related]
13. Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.
Birdsong WT; Arttamangkul S; Clark MJ; Cheng K; Rice KC; Traynor JR; Williams JT
J Neurosci; 2013 Feb; 33(9):4118-27. PubMed ID: 23447620
[TBL] [Abstract][Full Text] [Related]
14. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
Morgan MM; Clayton CC; Lane DA
Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152
[TBL] [Abstract][Full Text] [Related]
15. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
16. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats.
Lane DA; Patel PA; Morgan MM
Neuroscience; 2005; 135(1):227-34. PubMed ID: 16084660
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antinociception with repeated microinjections of apomorphine into the periaqueductal gray of male and female rats.
Schoo SM; Bobeck EN; Morgan MM
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):234-240. PubMed ID: 29256893
[TBL] [Abstract][Full Text] [Related]
18. Differences in antinociceptive signalling mechanisms following morphine and fentanyl microinjections into the rat periaqueductal gray.
Morgan MM; Tran A; Wescom RL; Bobeck EN
Eur J Pain; 2020 Mar; 24(3):617-624. PubMed ID: 31785128
[TBL] [Abstract][Full Text] [Related]
19. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
20. Involvement of local orphanin FQ in the tolerance induced by repeated microinjections of morphine into ventrolateral periaqueductal gray in rats.
Ge ZJ; Zhang LC; Zeng YM; Dai TJ; Chang L; Wang JK; Cui GX; Tan YF; Zhao YP; Liu GJ
Pharmacology; 2007; 80(4):261-8. PubMed ID: 17652947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
